Correction: Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions

被引:0
|
作者
Jalish M. Riyad
Thomas Weber
机构
[1] Icahn School of Medicine at Mount Sinai,Cardiovascular Institute
[2] Icahn School of Medicine at Mount Sinai,Graduate School of Biomedical Sciences
来源
Gene Therapy | 2021年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A Correction to this paper has been published: https://doi.org/10.1038/s41434-021-00252-y
引用
收藏
页码:771 / 771
相关论文
共 50 条
  • [41] Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
    Dwaipayan Sen
    Balaji Balakrishnan
    Nishanth Gabriel
    Prachi Agrawal
    Vaani Roshini
    Rekha Samuel
    Alok Srivastava
    Giridhara R. Jayandharan
    Scientific Reports, 3
  • [42] Improved Adeno-Associated Virus Serotype (AAV)5 Vectors for Hepatic Gene Therapy
    Sen, Dwaipayan
    Agarwal, Prachi
    Kalaivani, V.
    Srivastava, Alok
    Jayandharan, Giridhara R.
    MOLECULAR THERAPY, 2013, 21 : S207 - S208
  • [43] Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors
    Maeda, Y
    Ikeda, U
    Shimpo, M
    Ueno, S
    Ogasawara, Y
    Urabe, M
    Kume, A
    Takizawa, T
    Saito, T
    Colosi, P
    Kurtzman, G
    Shimada, K
    Ozawa, K
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (07) : 1341 - 1348
  • [44] Gene therapy of adeno-associated virus (AAV) vectors in preclinical models of ischemic stroke
    Wang, Jing
    Zhu, Mengna
    Sun, Jingyi
    Feng, Lina
    Yang, Mingfeng
    Sun, Baoliang
    Mao, Leilei
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (12) : 3725 - 3740
  • [45] Bioengineering of the adeno-associated virus (AAV) vectors for dendritic cell (DC)-based immunotherapy
    Jheel, Pandya
    Britt, Kellee
    Aslanidi, George
    CANCER RESEARCH, 2014, 74 (19)
  • [46] The Utilization of Capsid-Optimized Adeno-Associated Virus (AAV) Vectors for Cancer Immunotherapy
    Pandya, Munjal
    Britt, Kellee
    Ling, Chen
    Hoffman, Brad
    Aslanidi, George
    MOLECULAR THERAPY, 2015, 23 : S87 - S87
  • [47] Receptor targeting of adeno-associated virus vectors
    Büning, H
    Ried, MU
    Perabo, L
    Gerner, FM
    Huttner, NA
    Enssle, J
    Hallek, M
    GENE THERAPY, 2003, 10 (14) : 1142 - 1151
  • [48] GENE TARGETING WITH ADENO-ASSOCIATED VIRUS VECTORS
    Russell, David W.
    JOURNAL OF GENE MEDICINE, 2011, 13 (7-8): : 415 - 415
  • [49] Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
    Hacker, Ulrich T.
    Bentler, Martin
    Kaniowska, Dorota
    Morgan, Michael
    Buening, Hildegard
    CANCERS, 2020, 12 (07) : 1 - 30
  • [50] Biosafety of Recombinant Adeno-associated Virus Vectors
    Dismuke, David J.
    Tenenbaum, Liliane
    Samulski, R. Jude
    CURRENT GENE THERAPY, 2013, 13 (06) : 434 - 452